Healthcare2 months ago
Suven Life Sciences Limited (suven) Completes Patient Enrollment in Global Phase-3 Study of Masupirdine for Agitation Associated with Alzheimer’s Dementia
Suven Life Sciences Limited (SUVEN) completes patient enrollment in global Phase-3 study of Masupirdine for agitation associated with Alzheimer’s Dementia.
